We have a factory that is almost finalized, and usually for cancer, those products are ready ... cancer vaccine, named ...

Moderna and partner Merck & Co have fleshed out the data from their clinical trial of personalised mRNA vaccine for melanoma ... affordable option for health systems. At the moment, the time ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Merck’s business strategy focuses on discovering, developing, manufacturing, and marketing prescription drugs, vaccines, and animal health products ... with Moderna (MRNA) to develop mRNA ...